Relay Therapeutics, Inc. (RLAY)
14.08
+0.42
(+3.11%)
USD |
NASDAQ |
Jun 09, 16:00
13.81
-0.28
(-1.95%)
After-Hours: 18:41
Relay Therapeutics Shareholders Equity (Quarterly) : 642.18M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 670.81M |
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| Exelixis, Inc. | 1.936B |
| Insmed, Inc. | 704.85M |
| United Therapeutics Corp. | 5.901B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 699.61M |
| Total Liabilities (Quarterly) | 57.43M |
| Debt to Equity Ratio | 0.0492 |
| Current Ratio | 22.13 |
| Net Debt Paydown Yield | 0.18% |